文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肠道通透性在肝损伤发病机制中的作用:从非酒精性脂肪性肝病到肝移植。

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.

机构信息

Fondazione Policlinico Universitario A Gemelli IRCCS, Rome 00168, Italy.

出版信息

World J Gastroenterol. 2019 Sep 7;25(33):4814-4834. doi: 10.3748/wjg.v25.i33.4814.


DOI:10.3748/wjg.v25.i33.4814
PMID:31543676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6737313/
Abstract

The intimate connection and the strict mutual cooperation between the gut and the liver realizes a functional entity called gut-liver axis. The integrity of intestinal barrier is crucial for the maintenance of liver homeostasis. In this mutual relationship, the liver acts as a second firewall towards potentially harmful substances translocated from the gut, and is, in turn, is implicated in the regulation of the barrier. Increasing evidence has highlighted the relevance of increased intestinal permeability and consequent bacterial translocation in the development of liver damage. In particular, in patients with non-alcoholic fatty liver disease recent hypotheses are considering intestinal permeability impairment, diet and gut dysbiosis as the primary pathogenic trigger. In advanced liver disease, intestinal permeability is enhanced by portal hypertension. The clinical consequence is an increased bacterial translocation that further worsens liver damage. Furthermore, this pathogenic mechanism is implicated in most of liver cirrhosis complications, such as spontaneous bacterial peritonitis, hepatorenal syndrome, portal vein thrombosis, hepatic encephalopathy, and hepatocellular carcinoma. After liver transplantation, the decrease in portal pressure should determine beneficial effects on the gut-liver axis, although are incompletely understood data on the modifications of the intestinal permeability and gut microbiota composition are still lacking. How the modulation of the intestinal permeability could prevent the initiation and progression of liver disease is still an uncovered area, which deserves further attention.

摘要

肠道和肝脏之间的密切联系和严格的相互合作实现了一个功能实体,称为肠肝轴。肠道屏障的完整性对于维持肝脏内环境稳定至关重要。在这种相互关系中,肝脏作为从肠道易位的潜在有害物质的第二道防火墙,反过来又参与了屏障的调节。越来越多的证据强调了肠道通透性增加和随之而来的细菌易位在肝损伤发展中的相关性。特别是在非酒精性脂肪性肝病患者中,最近的假说认为肠道通透性损害、饮食和肠道菌群失调是主要的致病触发因素。在晚期肝病中,门静脉高压会增强肠道通透性。其临床后果是细菌易位增加,进一步加重肝损伤。此外,这种致病机制与大多数肝硬化并发症有关,如自发性细菌性腹膜炎、肝肾综合征、门静脉血栓形成、肝性脑病和肝细胞癌。肝移植后,门静脉压力的降低应该对肠肝轴产生有益的影响,但关于肠道通透性和肠道微生物群组成的改变的数据仍不完全了解。肠道通透性的调节如何预防肝病的发生和进展仍然是一个未被揭示的领域,值得进一步关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294e/6737313/a393d49f0642/WJG-25-4814-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294e/6737313/b8e748cfeda1/WJG-25-4814-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294e/6737313/a393d49f0642/WJG-25-4814-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294e/6737313/b8e748cfeda1/WJG-25-4814-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294e/6737313/a393d49f0642/WJG-25-4814-g002.jpg

相似文献

[1]
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.

World J Gastroenterol. 2019-9-7

[2]
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Hepatol Int. 2017-5-26

[3]
Gut-liver axis signaling in portal hypertension.

World J Gastroenterol. 2019-10-21

[4]
Potential mechanisms linking gut microbiota and portal hypertension.

Liver Int. 2018-11-9

[5]
Liver cirrhosis and complications from the perspective of dysbiosis.

Front Med (Lausanne). 2024-1-16

[6]
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.

Aliment Pharmacol Ther. 2017-10-30

[7]
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.

Sci Rep. 2017-9-22

[8]
Gut microbiota-related complications in cirrhosis.

World J Gastroenterol. 2014-11-14

[9]
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.

World J Gastroenterol. 2017-6-14

[10]
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.

J Hepatol. 2019-12

引用本文的文献

[1]
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Int J Mol Sci. 2025-6-14

[2]
Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases.

Front Nutr. 2025-3-24

[3]
Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis.

J Clin Med. 2025-2-23

[4]
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review.

Food Sci Nutr. 2025-3-10

[5]
The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights.

Front Microbiol. 2025-1-29

[6]
sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.

Microorganisms. 2024-12-3

[7]
Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease.

Clin Mol Hepatol. 2025-2

[8]
Bacterial contamination of autologous blood salvaged during deceased donor liver transplantation: a prospective observational study.

Sci Rep. 2024-11-5

[9]
Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction-associated steatotic liver disease: a comprehensive review.

J Gastroenterol Hepatol. 2025-1

[10]
Impact of High-Temperature Feeds on Gut Microbiota and MAFLD.

J Microbiol Biotechnol. 2024-9-28

本文引用的文献

[1]
Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.

Cell Death Differ. 2020-1

[2]
A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.

Ann Hepatol. 2019-4-15

[3]
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.

World J Gastroenterol. 2019-1-28

[4]
Potential mechanisms linking gut microbiota and portal hypertension.

Liver Int. 2018-11-9

[5]
Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.

Life Sci. 2018-8-7

[6]
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.

Expert Rev Gastroenterol Hepatol. 2018-6-6

[7]
Targeting Oxidative Stress for the Treatment of Liver Fibrosis.

Rev Physiol Biochem Pharmacol. 2018

[8]
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.

Hepatology. 2018-7-10

[9]
Maintenance of intestinal homeostasis by mucosal barriers.

Inflamm Regen. 2018-4-2

[10]
High MUC2 Mucin Expression and Misfolding Induce Cellular Stress, Reactive Oxygen Production, and Apoptosis in Goblet Cells.

Am J Pathol. 2018-3-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索